• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser37Profs*7 (c.109delT); ClinVar=VCV001713031; Zygosity=Unspecified (PubMed=23613873).
  

PubMed=15735012; DOI=10.1158/0008-5472.CAN-04-3665
van Zeeburg H.J.T., Snijders P.J.F., Pals G., Hermsen M.A.J.A., Rooimans M.A., Bagby G., Soulier J., Gluckman E., Wennerberg J., Leemans C.R., Joenje H., Brakenhoff R.H.
Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients.
Cancer Res. 65:1271-1276(2005)

PubMed=23613873; DOI=10.1371/journal.pone.0061555; PMCID=PMC3629194
Martens-de Kemp S.R., Dalm S.U., Wijnolts F.M.J., Brink A., Honeywell R.J., Peters G.J., Braakhuis B.J.M., Brakenhoff R.H.
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.
PLoS ONE 8:E61555-E61555(2013)

PubMed=25609062; DOI=10.1158/1078-0432.CCR-14-2616; PMCID=PMC4401632
Lombardi A.J., Hoskins E.E., Foglesong G.D., Wikenheiser-Brokamp K.A., Wiesmuller L., Hanenberg H., Andreassen P.R., Jacobs A.J., Olson S.B., Keeble W.W., Hays L.E., Wells S.I.
Acquisition of relative interstrand crosslinker resistance and PARP inhibitor sensitivity in Fanconi anemia head and neck cancers.
Clin. Cancer Res. 21:1962-1972(2015)

PubMed=36912284; DOI=10.1002/ijc.34506
Nguyen H.T., Tang W.-L., Webster A.L.H., Whiteaker J.R., Chandler C.M., Errazquin Ciudad R., Roohollahi K., Fritzke M., Hoskins E.E., Jonlin E.C., Wakefield L., Sullivan L.B., Chen E.Y., Dorsman J.C., Brakenhoff R.H., Paulovich A.G., Grompe M., Garcia-Escudero R., Wells S.I., Smogorzewska A., Monnat R.J. Jr.
Fanconi anemia-isogenic head and neck cancer cell line pairs: a basic and translational science resource.
Int. J. Cancer 153:183-196(2023)